54gene is an African genomics company building the world’s largest pan-African biobank. The company was founded in 2019 by Dr. Abasi Ene-Obong to unlock the African genome and improve our understanding of the world’s most genetically diverse population.
54gene is partnering with hospitals and research institutions in African countries; and with pharmaceutical and biotechnology companies to address the challenge of limited diverse genomics data, which may hold the key to medical discoveries and new healthcare solutions.
Backed by investors including Y Combinator, Fifty Years Ventures, Better Ventures, and KdT Ventures, 54gene aims to equilibrate healthcare for people of African origin while advancing the quality of medical care worldwide.
Abasi Ene-Obong PhD
Chief Executive Officer
Delali Attipoe
Chief Operations Officer
Jessica Rich
Chief Commercial Officer
Abi Galadima
Chief of Staff
Francis Osifo
VP of Engineering & Head of Technology, Africa
Estelle Dogbo
VP of Diagnostics & Country Head, Nigeria
Dr. Zara Modibbo
VP Laboratory OperationsHead of Clinical Laboratory Services, Africa
Aminu Yakubu
VP Research Planning & Ethics
Dr. Jumi Popoola
Director of Scientific Services, Africa
Dr. Nabila Ado Wanka
Head of Histopathology
Yemisi Osakwe
Director of Provider Engagement
Ijeoma Onuoha
Director, Ecosystem Partnerships, Africa
Find out more about our clinical tests, subscribe to our newsletter, or read the latest updates from our blog.
Email us at hello@54gene.com